Biological cells often possess thin, hair-like protrusions on their surface known as cilia, which serve various functions ranging from movement to sensing environmental signals. Researchers from ...

For the first time, scientists have identified promising drug candidates that bind irreversibly with a notoriously ...

Recent work in The EMBO Journal describes a new hybrid post-translational modification of proteins, composed of a poly-ubiquitin chain that is attached to a target protein via a mono-ADP-ribose (MAR) ...

Despite a crowded GLP-1 drug development field, Structure's oral small molecule approach and strong financial position offer ...

UPF researchers have led the creation of a computational simulator that is unique in the world to study one of the causes of ...

Lebrikizumab improves itch, sleep interference, and skin pain in atopic dermatitis patients previously treated with dupilumab, offering a new treatment option. A new Phase-3b study has found that ...

Please provide your email address to receive an email when new articles are posted on . Dupilumab was able to improve lichenification among patients aged 6 to 88 years with atopic dermatitis.

They included 25 patients who received dupilumab and had computed tomography (CT) scans before and 4 months after treatment. They compared clinical and CT parameters, including mucus plug score, wall ...

Protein structure predictions are bioinformatic analyses that produce predicted protein structures automatically using the protein amino acid sequence. Protein structures are important because ...

Protein can be found in many foods, but certain options can be better than others. From chicken to egg whites, consider these foods to pack your diet with protein. Protein is an essential ...

Whey protein is a supplement that some people use to increase their protein intake or to help boost muscle protein synthesis and lean muscle mass growth. Milk consists of two proteins: casein and ...

Thanks to the transformative nature of targeted protein degradation and our unique target selection ... In preclinical studies, KT-621 demonstrated dupilumab-like activity in several in vitro and in ...